Table of Contents

1 Market Overview
1.1 Low Molecular Weight Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Enoxaparin
1.2.2 Dalteparin
1.2.3 Tinzaparin
1.2.4 Fraxiparine
1.3 Market Analysis by Applications
1.3.1 Treatment of Venous Thromboembolism
1.3.2 Complications of Pregnancy
1.3.3 Cardioversion of Atrial Fibrillation/Flutter
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aspen
2.1.1 Business Overview
2.1.2 Low Molecular Weight Heparin Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi-aventis
2.2.1 Business Overview
2.2.2 Low Molecular Weight Heparin Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Low Molecular Weight Heparin Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Opocrin
2.4.1 Business Overview
2.4.2 Low Molecular Weight Heparin Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 CSBIO
2.5.1 Business Overview
2.5.2 Low Molecular Weight Heparin Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dongying Tiandong Pharmaceutical
2.6.1 Business Overview
2.6.2 Low Molecular Weight Heparin Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Changzhou Qianhong Bio-pharma
2.7.1 Business Overview
2.7.2 Low Molecular Weight Heparin Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Techdow
2.8.1 Business Overview
2.8.2 Low Molecular Weight Heparin Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Yantai Dongcheng Pharmaceutical Group
2.9.1 Business Overview
2.9.2 Low Molecular Weight Heparin Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Low Molecular Weight Heparin Market Competition, by Manufacturer
3.1 Global Low Molecular Weight Heparin Sales and Market Share by Manufacturer
3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Low Molecular Weight Heparin Manufacturer Market Share
3.3.2 Top 6 Low Molecular Weight Heparin Manufacturer Market Share
3.4 Market Competition Trend
4 Global Low Molecular Weight Heparin Market Analysis by Regions
4.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Regions
4.1.1 Global Low Molecular Weight Heparin Sales by Regions (2012-2017)
4.1.2 Global Low Molecular Weight Heparin Revenue by Regions (2012-2017)
4.2 North America Low Molecular Weight Heparin Sales and Growth (2012-2017)
4.3 Europe Low Molecular Weight Heparin Sales and Growth (2012-2017)
4.4 Asia-Pacific Low Molecular Weight Heparin Sales and Growth (2012-2017)
4.5 South America Low Molecular Weight Heparin Sales and Growth (2012-2017)
4.6 Middle East and Africa Low Molecular Weight Heparin Sales and Growth (2012-2017)
5 North America Low Molecular Weight Heparin by Countries
5.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
5.1.1 North America Low Molecular Weight Heparin Sales by Countries (2012-2017)
5.1.2 North America Low Molecular Weight Heparin Revenue by Countries (2012-2017)
5.2 USA Low Molecular Weight Heparin Sales and Growth (2012-2017)
5.3 Canada Low Molecular Weight Heparin Sales and Growth (2012-2017)
5.4 Mexico Low Molecular Weight Heparin Sales and Growth (2012-2017)
6 Europe Low Molecular Weight Heparin by Countries
6.1 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
6.1.1 Europe Low Molecular Weight Heparin Sales by Countries (2012-2017)
6.1.2 Europe Low Molecular Weight Heparin Revenue by Countries (2012-2017)
6.2 Germany Low Molecular Weight Heparin Sales and Growth (2012-2017)
6.3 UK Low Molecular Weight Heparin Sales and Growth (2012-2017)
6.4 France Low Molecular Weight Heparin Sales and Growth (2012-2017)
6.5 Russia Low Molecular Weight Heparin Sales and Growth (2012-2017)
6.6 Italy Low Molecular Weight Heparin Sales and Growth (2012-2017)
7 Asia-Pacific Low Molecular Weight Heparin by Countries
7.1 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Low Molecular Weight Heparin Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Low Molecular Weight Heparin Revenue by Countries (2012-2017)
7.2 China Low Molecular Weight Heparin Sales and Growth (2012-2017)
7.3 Japan Low Molecular Weight Heparin Sales and Growth (2012-2017)
7.4 Korea Low Molecular Weight Heparin Sales and Growth (2012-2017)
7.5 India Low Molecular Weight Heparin Sales and Growth (2012-2017)
7.6 Southeast Asia Low Molecular Weight Heparin Sales and Growth (2012-2017)
8 South America Low Molecular Weight Heparin by Countries
8.1 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
8.1.1 South America Low Molecular Weight Heparin Sales by Countries (2012-2017)
8.1.2 South America Low Molecular Weight Heparin Revenue by Countries (2012-2017)
8.2 Brazil Low Molecular Weight Heparin Sales and Growth (2012-2017)
8.3 Argentina Low Molecular Weight Heparin Sales and Growth (2012-2017)
8.4 Columbia Low Molecular Weight Heparin Sales and Growth (2012-2017)
9 Middle East and Africa Low Molecular Weight Heparin by Countries
9.1 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Low Molecular Weight Heparin Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Countries (2012-2017)
9.2 Saudi Arabia Low Molecular Weight Heparin Sales and Growth (2012-2017)
9.3 UAE Low Molecular Weight Heparin Sales and Growth (2012-2017)
9.4 Egypt Low Molecular Weight Heparin Sales and Growth (2012-2017)
9.5 Nigeria Low Molecular Weight Heparin Sales and Growth (2012-2017)
9.6 South Africa Low Molecular Weight Heparin Sales and Growth (2012-2017)
10 Global Low Molecular Weight Heparin Market Segment by Type
10.1 Global Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Type (2012-2017)
10.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2012-2017)
10.2 Enoxaparin Sales Growth and Price
10.2.1 Global Enoxaparin Sales Growth (2012-2017)
10.2.2 Global Enoxaparin Price (2012-2017)
10.3 Dalteparin Sales Growth and Price
10.3.1 Global Dalteparin Sales Growth (2012-2017)
10.3.2 Global Dalteparin Price (2012-2017)
10.4 Tinzaparin Sales Growth and Price
10.4.1 Global Tinzaparin Sales Growth (2012-2017)
10.4.2 Global Tinzaparin Price (2012-2017)
10.5 Fraxiparine Sales Growth and Price
10.5.1 Global Fraxiparine Sales Growth (2012-2017)
10.5.2 Global Fraxiparine Price (2012-2017)
11 Global Low Molecular Weight Heparin Market Segment by Application
11.1 Global Low Molecular Weight Heparin Sales Market Share by Application (2012-2017)
11.2 Treatment of Venous Thromboembolism Sales Growth (2012-2017)
11.3 Complications of Pregnancy Sales Growth (2012-2017)
11.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth (2012-2017)
11.5 Others Sales Growth (2012-2017)
12 Low Molecular Weight Heparin Market Forecast (2017-2022)
12.1 Global Low Molecular Weight Heparin Sales, Revenue and Growth Rate (2017-2022)
12.2 Low Molecular Weight Heparin Market Forecast by Regions (2017-2022)
12.2.1 North America Low Molecular Weight Heparin Market Forecast (2017-2022)
12.2.2 Europe Low Molecular Weight Heparin Market Forecast (2017-2022)
12.2.3 Asia-Pacific Low Molecular Weight Heparin Market Forecast (2017-2022)
12.2.4 South America Low Molecular Weight Heparin Market Forecast (2017-2022)
12.2.5 Middle East and Africa Low Molecular Weight Heparin Market Forecast (2017-2022)
12.3 Low Molecular Weight Heparin Market Forecast by Type (2017-2022)
12.4 Low Molecular Weight Heparin Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source